Volver a informes
Most-Favored- Nation’s Global Impact: The Future of Drug Pricing
Mobility is an essential element of modern life, a necessity that evolves with societal and technological changes. In an increasingly urbanized world, traditional modes of transportation are being challenged by environmental, economic, and social issues.
Accede al informe completo
A New Global Equation for Pharma Market Access Leaders
The new Most-Favored-Nation (MFN) regulation in the U.S. is poised to reshape the global drug pricing landscape.
In the report “Most-Favored-Nation’s Global Impact: The Future of Drug Pricing”, we examine how this regulation could shift the balance between the U.S. and Europe, exert downward pressure on drug prices, and accelerate the adoption of outcome-based pricing models worldwide.
¿Quieres acceder al informe completo?
Rellena el formulario para descargarlo gratis